HeartSciences (HSCS) Return on Equity (2022 - 2026)

HeartSciences has reported Return on Equity for 5 years, with the latest figure at 0.02% in Q1 2026.

• For the quarter ending Q1 2026, Return on Equity changed 0.0% year-over-year to 0.02%; the trailing twelve-month figure through Jan 2026 stood at 0.02% (changed 0.0% YoY), and the FY2025 full-year result was 0.02%, down 1.0% from the prior year.
• Return on Equity for Q1 2026 stood at 0.02%, down from 0.02% in the prior quarter.
• The five-year high for Return on Equity was 4.62% in Q2 2023, with the low at 0.16% in Q1 2023.
• Historically, Return on Equity has averaged 0.29% across 5 years, with a median of 0.02% in 2024.
• Annual changes were most pronounced in 2023 — Return on Equity surged 461 bps — and 2024, when it slumped 463 bps.
• HeartSciences' Return on Equity stood at 0.03% in 2022, then soared by 266 bps to 0.06% in 2023, then tumbled by 128 bps to 0.02% in 2024, then tumbled by 59 bps to 0.02% in 2025, then retreated by 1 bps to 0.02% in 2026.
• The last three Return on Equity figures came in at 0.02% (Q1 2026), 0.02% (Q4 2025), and 0.05% (Q3 2025), per Business Quant data.